Jordan pharmaceutical company to invest USD 100mn in Ukraine.

By bne IntelliNews April 17, 2012
One of the largest pharmaceutical companies Hikma Pharmaceuticals in the Jordan Hashemite Kingdom is planning to invest over USD 100mn in Ukraine, announced ambassador of Ukraine to Jordan Serhiy Pasko. We should note, that by results of 2011, the volumes of pharmaceutical retail sales grew by 11% on average (in the hryvnia). In natural terms, consumption growth made up about 5% (in tons). Today, on the market, out of registered medicaments, 34% are medicaments made in Ukraine, the rest - made abroad. In financial terms, approximately 70% of the market is occupied by imported medicaments, 30% - domestic. Main companies, importing pharmaceutical products and working in Ukraine, are as follows: BaDM, Optima-Farm Ltd, VVS-Ltd, Alba Ukraine, Sanofi-Aventis Ukraine, and others. Main foreign producers, whose products are presented on the Ukrainian market are as follows: Berlin-chemie/menarini Group (Germany), Nycomed (Austria), «KRKA (Slovenia), Sanofi-aventis (France), Gedeon Richter (Hungary).

Related Articles

Metro Ukraine raises sales by 11% y/y to EUR 877mn in 2012.

In 2012, Metro Cash&Carry Ukraine, which is a retail division of the Metro Group (Germany), raised sales by 10.9% y/y to EUR 877mn, the company said. The company opened two new wholesale ... more

NBU: Gross external debt of Ukraine up 2% q/q in Q4/2012

The Naftogaz Ukrainy has repaid UAH 2.4bn worth of loans so far in 2013. The company was able to repay this amount of loans because of economy of natural gas in all areas of its operation, ... more

EC makes new recommendations for Ukraine.

The European Commission recommends Ukraine to focus on meeting its commitments under the association agenda, reads the ENP Country Progress Report 2012 - Ukraine released on Wednesday. In ... more

Dismiss